| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.34B | 8.57B | 8.69B | 8.02B | 7.51B | 6.71B |
| Gross Profit | 784.60M | 892.65M | 989.29M | 681.78M | 524.86M | 350.40M |
| EBITDA | 1.06B | 1.56B | 1.70B | 1.42B | 1.25B | 1.58B |
| Net Income | 135.46M | 232.74M | 330.45M | 110.35M | 21.21M | 359.13M |
Balance Sheet | ||||||
| Total Assets | 5.79B | 5.98B | 6.51B | 7.18B | 6.87B | 7.15B |
| Cash, Cash Equivalents and Short-Term Investments | 965.27M | 1.05B | 1.26B | 1.67B | 1.59B | 2.09B |
| Total Debt | 3.11B | 2.13B | 2.45B | 3.25B | 3.10B | 3.23B |
| Total Liabilities | 3.14B | 3.24B | 3.60B | 4.38B | 4.05B | 4.12B |
| Stockholders Equity | 2.64B | 2.73B | 2.90B | 2.78B | 2.82B | 3.03B |
Cash Flow | ||||||
| Free Cash Flow | 1.16B | 1.21B | 1.35B | 1.25B | 675.69M | 1.42B |
| Operating Cash Flow | 1.44B | 1.51B | 1.66B | 1.71B | 1.17B | 1.70B |
| Investing Cash Flow | -271.31M | -254.05M | -263.01M | -452.32M | -469.81M | -284.87M |
| Financing Cash Flow | -1.28B | -1.46B | -1.80B | -1.16B | -1.20B | 287.96M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$1.17B | 5.43 | 10.47% | 5.56% | 4.16% | 59.08% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | HK$2.62B | 15.96 | 1.38% | 1.12% | -6.80% | -85.10% | |
55 Neutral | HK$2.62B | 19.78 | 5.05% | 6.90% | -3.45% | -50.11% | |
51 Neutral | HK$276.00M | -113.78 | -2.62% | 24.14% | -5.71% | -144.00% | |
47 Neutral | HK$993.30M | 8.83 | 0.39% | 7.11% | 0.26% | -73.09% |